{"cdcTestId":"2013-0439","testcaseName":"Any dose 26 yrs, female, Cervarix","vaccineGroup":"HPV","evaluationTestType":"Age: At Recommended","forecastTestType":"Recommended based on interval","assessmentDate":"2012-05-02T00:00:00","patient":{"dob":"1986-05-01T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2012-05-02T00:00:00","vaccineName":"CERVARIX","cvx":"118","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2012-05-30T00:00:00","recommendedDate":"2012-05-30T00:00:00","pastDueDate":"2012-08-21T00:00:00"},"doses":[{"dateAdministered":"2012-05-02T00:00:00","vaccineName":"CERVARIX","cvx":"118","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-15T08:43:33.445","generalDescription":"This test case describes when a patient 26 years of age has received dose number one of the HPV vaccine, that another dose should be forecast.","changedInVersion":"3.5","reasonForChange":"V3.5: Updated Recommended Date to reflect change in supporting data (v3.6) from 8 weeks to 4 weeks.\nV3.0 Updated test came name and date of birth to reflect the age of 26 and to reflect that the second dose of the HPV vaccine should be forecast."}